We hope to contribute to human health and happiness by participatingin the development of structure-based innovative drugs using Cryo-EM, Protein Engineering, and Quantum Computing 

Baobab AiBIO, founded in 2018, to reduce drug discovery time and costs through AI and structure-based design.
Supported by the Bioinformatics and Molecular Design Research Center,
a pioneer in computer-aided drug discovery, we verify results at each stage, focusing on target-ligand binding.
In June 2021, we established only cryo-electron microscopy system in a domestic biotech firm, leading to successful protein structure identifications.

everaging Cryo-EM and quantum mechanics, we offer tailored services to biopharmaceutical companies, enhancing antibody and preparing for future advancements in quantum computing.

Like the resilient baobab tree,

strive to enhance human health and quality of life.

CEO         Kyoungtai No